Biological Characteristics of Cluster of Differentiation 147 and Its Relationship with Tumour

Cen Gao1, Chao-Hui Lu1, Jie Chen1

  • 1Department of Pathology,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.

Insights

Cluster of differentiation 147 (CD147), also known as extracellular matrix metalloproteinase inducer (EMMPRIN), is a key protein on cancer cells. This review explores its structure, functions, and mechanisms in promoting tumor growth and spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cluster of differentiation 147 (CD147), or extracellular matrix metalloproteinase inducer (EMMPRIN), is a transmembrane glycoprotein.
  • It belongs to the immunoglobulin superfamily and is highly expressed on malignant tumor cells.

Purpose of the Study:

  • This review synthesizes current knowledge on the structural and biological characteristics of CD147.
  • It focuses on the multifaceted roles of CD147 in various cancers and the underlying molecular mechanisms.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of structural and functional data related to CD147.
  • Synthesis of information on CD147's role in cancer progression.

Main Results:

  • CD147 stimulates matrix metalloproteinase production in the tumor microenvironment.
  • It promotes cancer cell growth, invasion, metastasis, glycolysis, angiogenesis, and resistance to multidrugs and anoikis.
  • CD147 also inhibits starvation-induced autophagy.

Conclusions:

  • CD147 plays a critical role in multiple aspects of cancer progression.
  • Understanding CD147's functions and mechanisms is crucial for developing targeted cancer therapies.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K